Use of thrombolytic agents in the treatment of acute pulmonary thromboembolism: things are not as simple as you might thinkReflections on the use of thrombolytic agents in acute pulmonary embolismReperfusion in acute pulmonary thromboembolismFibrinolysis for patients with intermediate-risk pulmonary embolismImpact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism
- PMID: 30758431
- PMCID: PMC6534414
- DOI: 10.1590/1806-3713/e20180297
Use of thrombolytic agents in the treatment of acute pulmonary thromboembolism: things are not as simple as you might thinkReflections on the use of thrombolytic agents in acute pulmonary embolismReperfusion in acute pulmonary thromboembolismFibrinolysis for patients with intermediate-risk pulmonary embolismImpact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism
Comment on
-
Reperfusion in acute pulmonary thromboembolism.J Bras Pneumol. 2018 Jun 7;44(3):0. doi: 10.1590/S1806-37562017000000204. Online ahead of print. J Bras Pneumol. 2018. PMID: 29898007 Free PMC article.
References
-
- Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–3069. - PubMed
-
- Verstraete M. Thrombolytic treatment in acute myocardial infarction. Circulation. 1990;82(3 Suppl):II96–I109. - PubMed
-
- Brasil. Ministério da Saúde . Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Portaria No. 37. 1. Vol. 176. Diário Oficial da União; 2018. pp. 203–203.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical